{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:15Z","timestamp":1791639555417,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Thammasat University Research Fund","award":["TUGT 4\/2562"],"award-info":[{"award-number":["TUGT 4\/2562"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dengue virus (DENV) infection can lead to severe outcomes through a virus-induced cytokine storm, resulting in vascular leakage and inflammation. An effective treatment strategy should target both virus replication and cytokine storm. This study identified <jats:italic>Kaempferia galanga<\/jats:italic> L. (KG) extract as exhibiting anti-DENV activity. The major bioactive compound, ethyl-p-methoxycinnamate (EPMC), significantly reduced DENV-2 infection, virion production, and viral protein synthesis in HepG2 and A549 cells, with half-maximal effective concentration (EC<jats:sub>50<\/jats:sub>) values of 22.58\u00a0\u00b5M and 6.17\u00a0\u00b5M, and impressive selectivity indexes (SIs) of 32.40 and 173.44, respectively. EPMC demonstrated efficacy against all four DENV serotypes, targeting the replication phase of the virus life cycle. Importantly, EPMC reduced DENV-2-induced cytokines (IL-6 and TNF-\u03b1) and chemokines (RANTES and IP-10), as confirmed by immunofluorescence and immunoblot analyses, indicating inhibition of NF-\u03baB activation. EPMC's role in preventing excessive inflammatory responses suggests it as a potential candidate for dengue treatment. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) and drug-likeness for EPMC were predicted using SwissADME and ProTox II servers, showing good drug-like properties without toxicity. These findings highlight KG extract and EPMC as promising candidates for future anti-dengue therapeutics, offering a dual-action approach by inhibiting virus replication and mitigating inflammatory reactions.<\/jats:p>","DOI":"10.1038\/s41598-024-60070-1","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:01:49Z","timestamp":1713873709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dual action effects of ethyl-p-methoxycinnamate against dengue virus infection and inflammation via NF-\u03baB pathway suppression"],"prefix":"10.1038","volume":"14","author":[{"given":"Mayuri","family":"Tarasuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pucharee","family":"Songprakhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phunuch","family":"Muhamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aussara","family":"Panya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pachara","family":"Sattayawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-thai","family":"Yenchitsomanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"60070_CR1","unstructured":"World Health Organization. Dengue and severe dengue. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue. 17 March (2023)."},{"key":"60070_CR2","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","volume":"35","author":"SB Halstead","year":"2017","unstructured":"Halstead, S. B. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35, 6355\u20136358. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.089 (2017).","journal-title":"Vaccine"},{"key":"60070_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/infdis\/jiac424","volume":"227","author":"A de Silva","year":"2022","unstructured":"de Silva, A. & White, L. Immunogenicity of a live dengue vaccine (TAK-003). J. Infect. Dis. 227, 163\u2013164. https:\/\/doi.org\/10.1093\/infdis\/jiac424 (2022).","journal-title":"J. Infect. Dis."},{"key":"60070_CR4","unstructured":"Liu, A. UPDATED: Takeda yanks FDA filing for dengue vaccine, citing data disagreement with regulator. https:\/\/www.fiercepharma.com\/pharma\/Takeda-yanks-fda-application-dengue-vaccine-citing-data-collection-disagreement (11 July 2023)."},{"key":"60070_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154780","volume":"123","author":"RA Khan","year":"2019","unstructured":"Khan, R. A., Afroz, S., Minhas, G., Battu, S. & Khan, N. Dengue virus envelope protein domain III induces pro-inflammatory signature and triggers activation of inflammasome. Cytokine 123, 154780. https:\/\/doi.org\/10.1016\/j.cyto.2019.154780 (2019).","journal-title":"Cytokine"},{"key":"60070_CR6","doi-asserted-by":"publisher","first-page":"304ra142","DOI":"10.1126\/scitranslmed.aaa3863","volume":"7","author":"N Modhiran","year":"2015","unstructured":"Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142. https:\/\/doi.org\/10.1126\/scitranslmed.aaa3863 (2015).","journal-title":"Sci. Transl. Med."},{"key":"60070_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/605847","volume":"200","author":"M Mazzon","year":"2009","unstructured":"Mazzon, M., Jones, M., Davidson, A., Chain, B. & Jacobs, M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J. Infect. Dis. 200, 1261\u20131270. https:\/\/doi.org\/10.1086\/605847 (2009).","journal-title":"J. Infect. Dis."},{"key":"60070_CR8","doi-asserted-by":"publisher","first-page":"11053","DOI":"10.1128\/JVI.79.17.11053-11061.2005","volume":"79","author":"CL Medin","year":"2005","unstructured":"Medin, C. L., Fitzgerald, K. A. & Rothman, A. L. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79, 11053\u201311061. https:\/\/doi.org\/10.1128\/JVI.79.17.11053-11061.2005 (2005).","journal-title":"J. Virol."},{"key":"60070_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbrc.2012.05.137","volume":"423","author":"S Khunchai","year":"2012","unstructured":"Khunchai, S. et al. Interaction of dengue virus nonstructural protein 5 with Daxx modulates RANTES production. Biochem. Biophys. Res. Commun. 423, 398\u2013403. https:\/\/doi.org\/10.1016\/j.bbrc.2012.05.137 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"60070_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cellimm.2010.02.005","volume":"262","author":"B Sierra","year":"2010","unstructured":"Sierra, B. et al. Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation?. Cell. Immunol. 262, 134\u2013140. https:\/\/doi.org\/10.1016\/j.cellimm.2010.02.005 (2010).","journal-title":"Cell. Immunol."},{"key":"60070_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/v11010034","volume":"11","author":"ARK Patro","year":"2019","unstructured":"Patro, A. R. K. et al. Cytokine signature associated with disease severity in dengue. Viruses 11, 34. https:\/\/doi.org\/10.3390\/v11010034 (2019).","journal-title":"Viruses"},{"key":"60070_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.humimm.2021.03.003","volume":"82","author":"S Gowri Sankar","year":"2021","unstructured":"Gowri Sankar, S. & Alwin Prem Anand, A. Cytokine IP-10 and GM-CSF are prognostic biomarkers for severity in secondary dengue infection. Hum. Immunol. 82, 438\u2013445. https:\/\/doi.org\/10.1016\/j.humimm.2021.03.003 (2021).","journal-title":"Hum. Immunol."},{"key":"60070_CR13","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1099\/vir.0.82093-0","volume":"87","author":"YR Lee","year":"2006","unstructured":"Lee, Y. R. et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever\/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 87, 3623\u20133630. https:\/\/doi.org\/10.1099\/vir.0.82093-0 (2006).","journal-title":"J. Gen. Virol."},{"key":"60070_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2334-8-86","volume":"8","author":"FA Bozza","year":"2008","unstructured":"Bozza, F. A. et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 8, 86. https:\/\/doi.org\/10.1186\/1471-2334-8-86 (2008).","journal-title":"BMC Infect. Dis."},{"key":"60070_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4269\/ajtmh.19-0487","volume":"102","author":"HA Imad","year":"2020","unstructured":"Imad, H. A. et al. Cytokine expression in dengue fever and dengue hemorrhagic fever patients with bleeding and severe hepatitis. Am. J. Trop. Med. Hyg. 102, 943\u2013950. https:\/\/doi.org\/10.4269\/ajtmh.19-0487 (2020).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60070_CR16","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1038\/ncomms11653","volume":"7","author":"B van Wilgenburg","year":"2016","unstructured":"van Wilgenburg, B. et al. MAIT cells are activated during human viral infections. Nat. Commun. 7, 11653. https:\/\/doi.org\/10.1038\/ncomms11653 (2016).","journal-title":"Nat. Commun."},{"key":"60070_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2015.10.005","volume":"124","author":"T Rattanaburee","year":"2015","unstructured":"Rattanaburee, T. et al. Inhibition of dengue virus production and cytokine\/chemokine expression by ribavirin and compound A. Antiv. Res. 124, 83\u201392. https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.005 (2015).","journal-title":"Antiv. Res."},{"key":"60070_CR18","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1038\/s41598-022-20284-7","volume":"12","author":"M Tarasuk","year":"2022","unstructured":"Tarasuk, M. et al. Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-\u03baB)-mediated inflammation in dengue virus infection. Sci. Rep. 12, 16088. https:\/\/doi.org\/10.1038\/s41598-022-20284-7 (2022).","journal-title":"Sci. Rep."},{"key":"60070_CR19","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00705-021-05017-x","volume":"166","author":"P Yongpitakwattana","year":"2021","unstructured":"Yongpitakwattana, P., Morchang, A., Panya, A., Sawasdee, N. & Yenchitsomanus, P. T. Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine\/chemokine expression in dendritic cells. Arch. Virol. 166, 1623\u20131632. https:\/\/doi.org\/10.1007\/s00705-021-05017-x (2021).","journal-title":"Arch. Virol."},{"key":"60070_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","volume":"46","author":"G Indrayanto","year":"2021","unstructured":"Indrayanto, G., Putra, G. S. & Suhud, F. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles Drug Subst. Excip. Relat. Methodol. 46, 273\u2013307. https:\/\/doi.org\/10.1016\/bs.podrm.2020.07.005 (2021).","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"60070_CR21","doi-asserted-by":"publisher","first-page":"675350","DOI":"10.3389\/fphar.2021.675350","volume":"12","author":"SY Wang","year":"2021","unstructured":"Wang, S. Y. et al. Kaempferia galanga L.: progresses in phytochemistry, pharmacology, toxicology and ethnomedicinal uses. Front. Pharmacol. 12, 675350. https:\/\/doi.org\/10.3389\/fphar.2021.675350 (2021).","journal-title":"Front. Pharmacol."},{"key":"60070_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43094-021-00394-1","volume":"8","author":"FP Nonglang","year":"2022","unstructured":"Nonglang, F. P., Khale, A. & Bhan, S. Phytochemical characterization of the ethanolic extract of Kaempferia galanga rhizome for anti-oxidant activities by HPTLC and GCMS. Futur. J. Pharm. Sci. 8, 9. https:\/\/doi.org\/10.1186\/s43094-021-00394-1 (2022).","journal-title":"Futur. J. Pharm. Sci."},{"key":"60070_CR23","first-page":"13","volume":"55","author":"AM Vittalrao","year":"2011","unstructured":"Vittalrao, A. M., Shanbhag, T., Kumari, M., Bairy, K. L. & Shenoy, S. Evaluation of antiinflammatory and analgesic activities of alcoholic extract of Kaempferia galanga in rats. Indian J. Physiol. Pharmacol. 55, 13\u201324 (2011).","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"60070_CR24","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.3390\/molecules17078720","volume":"17","author":"MI Umar","year":"2012","unstructured":"Umar, M. I. et al. Bioactivity-guided isolation of ethyl-p-methoxycinnamate, an anti-inflammatory constituent, from Kaempferia galanga L. extracts. Molecules 17, 8720\u20138734. https:\/\/doi.org\/10.3390\/molecules17078720 (2012).","journal-title":"Molecules"},{"key":"60070_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jtcme.2021.06.004","volume":"11","author":"LP Dwita","year":"2021","unstructured":"Dwita, L. P., Hikmawanti, N. P. E., Yeni, & Supandi,. Extract, fractions, and ethyl-p-methoxycinnamate isolate from Kaempferia galanga elicit anti-inflammatory activity by limiting leukotriene B4 (LTB4) production. J. Tradit. Complement. Med. 11, 563\u2013569. https:\/\/doi.org\/10.1016\/j.jtcme.2021.06.004 (2021).","journal-title":"J. Tradit. Complement. Med."},{"key":"60070_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.6061\/clinics\/2014(02)10","volume":"69","author":"MI Umar","year":"2014","unstructured":"Umar, M. I. et al. Ethyl-p-methoxycinnamate isolated from Kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-\u03b1, and angiogenesis by blocking endothelial functions. Clinics (Sao Paulo). 69, 134\u2013144. https:\/\/doi.org\/10.6061\/clinics\/2014(02)10 (2014).","journal-title":"Clinics (Sao Paulo)."},{"key":"60070_CR27","doi-asserted-by":"publisher","first-page":"114573","DOI":"10.1016\/j.jviromet.2022.114573","volume":"307","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Antiviral effect of an extract from Kaempferia galanga L. rhizome in mice infected with pseudorabies virus. J. Virol. Methods 307, 114573. https:\/\/doi.org\/10.1016\/j.jviromet.2022.114573 (2022).","journal-title":"J. Virol. Methods"},{"key":"60070_CR28","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"60070_CR29","first-page":"82","volume":"5","author":"CA Lipinski","year":"2002","unstructured":"Lipinski, C. A. Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 5, 82\u201385 (2002).","journal-title":"Am. Pharm. Rev."},{"key":"60070_CR30","doi-asserted-by":"crossref","unstructured":"Egan, W. J. Predicting ADME properties in drug discovery in Drug design: structure-and ligand-based approaches (ed. Merz, K. M. Jr., Ringe, D., Reynolds, C. H.) 165\u2013173 (Cambridge University Press, 2010).","DOI":"10.1017\/CBO9780511730412.013"},{"key":"60070_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/0471141755.ph0912s49","volume":"49","author":"MP Pollastri","year":"2010","unstructured":"Pollastri, M. P. Overview on the rule of five. Curr. Protoc. Pharmacol. 49, 9\u201312. https:\/\/doi.org\/10.1002\/0471141755.ph0912s49 (2010).","journal-title":"Curr. Protoc. Pharmacol."},{"key":"60070_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271956","volume":"17","author":"A Gadnayak","year":"2022","unstructured":"Gadnayak, A. et al. Mechanistic insights into 5-lipoxygenase inhibition by active principles derived from essential oils of Curcuma species: Molecular docking, ADMET analysis and molecular dynamic simulation study. PloS One 17, e0271956. https:\/\/doi.org\/10.1371\/journal.pone.0271956 (2022).","journal-title":"PloS One"},{"key":"60070_CR33","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K. & Preissner, R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 46, W257\u2013W263. https:\/\/doi.org\/10.1093\/nar\/gky318 (2018).","journal-title":"Nucleic Acids Res."},{"key":"60070_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.31788\/RJC.2020.1325638","volume":"13","author":"RA Syahputra","year":"2020","unstructured":"Syahputra, R. A. et al. In-silico toxicity prediction of bioactive compounds of Vernonia amygdalina Delile. and digoxin. Rasayan J. Chem. 13, 1220\u20131224 (2020).","journal-title":"Rasayan J. Chem."},{"key":"60070_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12906-017-1713-4","volume":"17","author":"A Amuamuta","year":"2017","unstructured":"Amuamuta, A., Plengsuriyakarn, T. & Na-Bangchang, K. Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. rhizome ethanolic extract. BMC Complement. Altern. Med. 17, 213. https:\/\/doi.org\/10.1186\/s12906-017-1713-4 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"60070_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800098-4.00001-5","volume":"88","author":"EG Acosta","year":"2014","unstructured":"Acosta, E. G., Kumar, A. & Bartenschlager, R. Revisiting dengue virus-host cell interaction: New insights into molecular and cellular virology. Adv. Virus Res. 88, 1\u2013109. https:\/\/doi.org\/10.1016\/B978-0-12-800098-4.00001-5 (2014).","journal-title":"Adv. Virus Res."},{"key":"60070_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jinf.2009.10.003","volume":"60","author":"TM Concei\u00e7\u00e3o","year":"2010","unstructured":"Concei\u00e7\u00e3o, T. M. et al. Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J. Infect. 60, 65\u201375. https:\/\/doi.org\/10.1016\/j.jinf.2009.10.003 (2010).","journal-title":"J. Infect."},{"key":"60070_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virusres.2007.03.003","volume":"126","author":"YR Lee","year":"2007","unstructured":"Lee, Y. R. et al. Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res. 126, 216\u2013225. https:\/\/doi.org\/10.1016\/j.virusres.2007.03.003 (2007).","journal-title":"Virus Res."},{"key":"60070_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"SP Lim","year":"2015","unstructured":"Lim, S. P., Noble, C. G. & Shi, P. Y. The dengue virus NS5 protein as a target for drug discovery. Antivir. Res. 119, 57\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2015.04.010 (2015).","journal-title":"Antivir. Res."},{"key":"60070_CR40","doi-asserted-by":"publisher","first-page":"198995","DOI":"10.1016\/j.virusres.2022.198995","volume":"323","author":"YM Brand","year":"2023","unstructured":"Brand, Y. M. et al. A new host-targeted antiviral cyclolignan (SAU-22.107) for Dengue Virus infection in cell cultures. Potential action mechanisms based on cell imaging. Virus Res. 323, 198995. https:\/\/doi.org\/10.1016\/j.virusres.2022.198995 (2023).","journal-title":"Virus Res."},{"key":"60070_CR41","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1038\/s41598-019-45095-1","volume":"9","author":"E Jung","year":"2019","unstructured":"Jung, E. et al. Neutralization of acidic intracellular vesicles by niclosamide inhibits multiple steps of the dengue virus life cycle in vitro. Sci. Rep. 9, 8682. https:\/\/doi.org\/10.1038\/s41598-019-45095-1 (2019).","journal-title":"Sci. Rep."},{"key":"60070_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.virusres.2014.12.007","volume":"197","author":"S Khunchai","year":"2015","unstructured":"Khunchai, S. et al. NF-\u03baB is required for dengue virus NS5-induced RANTES expression. Virus Res. 197, 92\u2013100. https:\/\/doi.org\/10.1016\/j.virusres.2014.12.007 (2015).","journal-title":"Virus Res."},{"key":"60070_CR43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00705-011-0969-0","volume":"156","author":"BM Silva","year":"2011","unstructured":"Silva, B. M. et al. The dengue virus nonstructural protein 1 (NS1) increases NF-\u03baB transcriptional activity in HepG2 cells. Arch. Virol. 156, 1275\u20131279. https:\/\/doi.org\/10.1007\/s00705-011-0969-0 (2011).","journal-title":"Arch. Virol."},{"key":"60070_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3923\/ajps.2022.183.191","volume":"21","author":"S Lallo","year":"2022","unstructured":"Lallo, S., Hardianti, B., Sartini, S., Ismail, I. & Hayakawa, Y. Anti-inflammatory and cytoprotective effect of Kaempferia galanga extracts by targeting NF-\u03baB activity. Asian J. Plant Sci. 21, 183\u2013191 (2022).","journal-title":"Asian J. Plant Sci."},{"key":"60070_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/life12030337","volume":"12","author":"S Lallo","year":"2022","unstructured":"Lallo, S. et al. Ethyl p-methoxycinnamate: An active anti-metastasis agent and chemosensitizer targeting NF-\u03baB from Kaempferia galanga for melanoma cells. Life (Basel) 12, 337. https:\/\/doi.org\/10.3390\/life12030337 (2022).","journal-title":"Life (Basel)"},{"key":"60070_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jep.2003.10.020","volume":"90","author":"D Kanjanapothi","year":"2004","unstructured":"Kanjanapothi, D. et al. Toxicity of crude rhizome extract of Kaempferia galanga L. (Proh Hom). J. Ethnopharmacol. 90, 359\u2013365. https:\/\/doi.org\/10.1016\/j.jep.2003.10.020 (2004).","journal-title":"J. Ethnopharmacol."},{"key":"60070_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.6026\/97320630010460","volume":"10","author":"MT Qamar","year":"2014","unstructured":"Qamar, M. T. et al. Molecular docking based screening of plant flavonoids as dengue NS1 inhibitors. Bioinformation 10, 460\u2013465. https:\/\/doi.org\/10.6026\/97320630010460 (2014).","journal-title":"Bioinformation"},{"key":"60070_CR48","doi-asserted-by":"publisher","first-page":"35638","DOI":"10.1074\/jbc.M400460200","volume":"279","author":"D Benarroch","year":"2004","unstructured":"Benarroch, D. et al. A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2019-O-methyltransferase domain by ribavirin 5\u2032-triphosphate. J. Biol. Chem. 279, 35638\u201335643. https:\/\/doi.org\/10.1074\/jbc.M400460200 (2004).","journal-title":"J. Biol. Chem."},{"key":"60070_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005737","volume":"12","author":"SP Lim","year":"2016","unstructured":"Lim, S. P. et al. Potent allosteric dengue virus NS5 polymerase inhibitors: Mechanism of action and resistance profiling. PLoS Pathog. 12, e1005737. https:\/\/doi.org\/10.1371\/journal.ppat.1005737 (2016).","journal-title":"PLoS Pathog."},{"key":"60070_CR50","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1021\/cb400612h","volume":"8","author":"M Yildiz","year":"2013","unstructured":"Yildiz, M., Ghosh, S., Bell, J. A., Sherman, W. & Hardy, J. A. Allosteric inhibition of the NS2B-NS3 protease from dengue virus. ACS Chem. Biol. 8, 2744\u20132752. https:\/\/doi.org\/10.1021\/cb400612h (2013).","journal-title":"ACS Chem. Biol."},{"key":"60070_CR51","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","volume":"79","author":"T Xu","year":"2005","unstructured":"Xu, T. et al. Structure of the dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J. Virol. 79, 10278\u201310288. https:\/\/doi.org\/10.1128\/JVI.79.16.10278-10288.2005 (2005).","journal-title":"J. Virol."},{"key":"60070_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W. & Taylor, R. D. Improved protein-ligand docking using GOLD. Proteins 52, 609\u2013623. https:\/\/doi.org\/10.1002\/prot.10465 (2003).","journal-title":"Proteins"},{"key":"60070_CR53","first-page":"21","volume":"10","author":"DS Biovia","year":"2000","unstructured":"Biovia, D. S. et al. Dassault Syst\u00e8mes, BIOVIA discovery studio visualizer, V. 17.2, San Diego: Dassault Syst\u00e8mes. J. Chem. Phys. 10, 21 (2000).","journal-title":"J. Chem. Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60070-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:19:56Z","timestamp":1713874796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60070-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["60070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-60070-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9322"}}